Scientific Advisors
Daniel J. Clauw, MD - Chair
Lesley Mussio Arnold, MD
Joel D. Baines, VMD, PhD
Lesley Mussio Arnold, MD, is a Professor of Psychiatry and Behavioral Neuroscience at the University of Cincinnati College of Medicine in Cincinnati, Ohio. She is also the Director of the Women’s Health Research Program at the University of Cincinnati Medical Center as well as the Director of the Fibromyalgia Treatment Program at UC Health in Cincinnati.
Dr. Arnold received her medical degree from the University of Cincinnati College of Medicine. She then served a residency in psychiatry and a clinical and research fellowship in consultation/liaison psychiatry at the University of Cincinnati Medical Center.
Dr. Arnold is board certified by the American Board of Psychiatry and Neurology. She is the Associate Editor of Pain Medicine and serves as a reviewer for many other professional journals, including Psychosomatics, Psychosomatic Medicine, Epilepsia, Mayo Clinic Proceedings, Current Psychiatry, Journal of Rheumatology, and Journal of Women’s Health, among others. Dr. Arnold’s major research interests are fibromyalgia and chronic pain, women’s health, mood and anxiety disorders, and psychocutaneous disorders, and she lectures widely on these and other topics. In addition, she is the author or coauthor of more than 135 original reports, reviews, and book chapters, and she has served as the principal investigator or a coinvestigator in more than 100 clinical research studies.
Joel Baines is dean of the Louisiana State University School of Veterinary Medicine and holds the Dr. Kenneth F. Burns Chair in Veterinary Medicine. Dr. Baines came to LSU from the Cornell University College of Veterinary Medicine in September 2014 where he served as the James Law Professor of Virology and Associate Dean for Research and Graduate Studies.
Dr. Baines received a VMD degree from the University of Pennsylvania in Philadelphia and a Ph.D. in virology from Cornell University. He was then a postdoctoral fellow for 5 years in the laboratory of Dr. Bernard Roizman at the University of Chicago, where he studied the molecular virology of herpes simplex virus replication.
Dr. Baines is a member of the American Veterinary Medical Society, the American Society of Microbiology, the American Association for Advancement of Science, and the American Society of Virology. He has served as a member of the editorial board for Journal of Virology, American Journal of Veterinary Research, and Virology; as an Associate Editor of PLOS Pathogens; and as a reviewer for many professional journals, including the American Journal of Veterinary Research, the Archives of Virology, the Journal of American Veterinary Medical Association, the Journal of Molecular Biology, and the Journal of Virology, among others. Dr. Baines is the author or coauthor of more than 90 peer-reviewed articles, monographs, and invited reviews. He has been funded by the NIH since 1995 to study herpes simplex virus.
Daniel Clauw is a Professor of Anesthesiology, Medicine (Rheumatology) and Psychiatry at the University of Michigan. He serves as Director of the Chronic Pain and Fatigue Research Center. Until January 2009 he also served as the first Associate Dean for Clinical and Translational Research within the University of Michigan Medical School, and PI of the UM Clinical and Translational Sciences Award (CTSA).
He attended the University of Michigan for both undergraduate and medical school studies and completed his Internal Medicine residency and Rheumatology Fellowship at Georgetown University. He joined the faculty at Georgetown University in 1990, and while there, founded the Georgetown Chronic Pain and Fatigue Research Center, and served as the Division Chief of Rheumatology, Immunology and Allergy, as well as Vice Chair of the Department of Medicine. Since moving to UM in 2001, Dr. Clauw has continued his commitment to the clinical care and research into overlapping conditions such as Fibromyalgia, Gulf War Illnesses, and Interstitial Cystitis just to name a few. He is an internationally known expert in chronic pain, especially the central nervous system contributions to chronic pain states, performing past or ongoing work in conditions such as low back pain, osteoarthritis, vulvodynia, endometriosis, irritable bowel syndrome, and temporomandibular joint disorder.
Dedra Stefanie Buchwald, MD, FACP
Michael Camilleri, M.D.
Richard James Whitley, MD
Dedra Stefanie Buchwald, MD, is a Professor in the Department of Epidemiology at the University of Washington School of Public Health,
a Professor in the Department of Medicine at the University of Washington School of Medicine, and an Adjunct Professor at the University of Washington School of Psychiatry in Seattle.
Dr. Buchwald received her medical degree at University of California, San Diego, School of Medicine. She then served a residency in internal medicine at Duke University Medical Center in Durham, North Carolina, and was a Henry J. Kaiser Family Foundation fellow in general internal medicine at Brigham and Women’s Hospital, Harvard Medical School, in Boston, Massachusetts.
Dr. Buchwald is board certified by the American Board of Internal Medicine. She is a fellow of the American College of Physicians and a member of the Society of General Internal Medicine, the American Epidemiological Society, and the Washington State Medical Association. Dr. Buchwald’s research interests include twin studies, fatigue and chronic fatigue syndrome, chronic pain and fibromyalgia, and American Indian and Alaska Native health. She is the author or coauthor of more than 270 refereed research articles, as well as book chapters and other nonrefereed scholarly materials.
Dr. Camilleri is Professor of Medicine (Gastroenterology), Pharmacology and Physiology at Mayo Clinic in Rochester, Minnesota. Through diverse methods, many of which were developed in his lab at Mayo Clinic, Dr. Camilleri studies gastrointestinal diseases that arise within the gut itself, as well as diseases in which the gastrointestinal tract is secondarily affected. His focus areas include diabetic gastroparesis, obesity, Irritable bowel syndrome and chronic constipation, bile acid diarrhea, pharmacogentics and novel pharmacotherapeutics.
Dr. Camilleri received his medical degree from the University of Malta Medical School, was Fellow - Internal Medicine and Gastroenterological Association (AGA) at Hammersmith Hospital, University of London and Fellow - Research at Mayo Clinic Graduate School of Biomedical Sciences. He was president of the American Gastroenterological Association (AGA) from 2014 – 2015 and President of the American Motility Society from 2008 - 2010. He is currently Executive Dean, Department of Development at the Mayo Clinic. Dr. Camilleri holds several grants from the NIH and was a recipient for 10 years of a K24 (mentorship, mid-career award) from NIH. Dr. Camilleri has over 700
publications.
Richard James Whitley, MD, is a Distinguished Professor of Pediatrics and a Professor of Microbiology, Medicine, and Neurosurgery at the University of Alabama at Birmingham (UAB). He is also Loeb Eminent Scholar Chair in Pediatrics; Co-Director of the Division of Pediatric Infectious Diseases; Vice-Chair of the Department of Pediatrics; Senior Scientist in the Department of Gene Therapy; Scientist at the Cancer Research and Training Center; Faculty at the Gene Therapy Center; Senior Leader of the Pediatric Oncology Program at the Comprehensive Cancer Center; Director of the UAB Center for Emerging Drug Discovery; and Co-Founder and Co-Director of the Alabama Drug Discovery Alliance.
Dr. Whitley received his medical degree from George Washington University. He then served a residency in pediatrics and
a fellowship in infectious diseases/virology at the University of Alabama at Birmingham.
Dr. Whitley is board certified by the American Board of Pediatrics, with a subspecialty in infectious diseases. He is Associate Editor of Journal of Infectious Diseases and is a member of the editorial board of many other scholarly journals, including Antimicrobial Agents and Chemotherapy, Reviews of Infectious Diseases, Human Gene Therapy, and Current Opinion in Infectious Diseases.
Dr. Whitley’s major research interests include antiviral therapies directed against medically important viral diseases of children and adults, including neonatal herpes simplex virus infection, herpes simplex encephalitis, herpes zoster, enteroviral infections of the newborn, therapeutic interventions for congenital cytomegalovirus infections, hepatitis C, and respiratory virus diseases in the immunocompromised host; and the translation of molecular biology to clinical application, particularly in the development of human monoclonal antibodies for therapy of herpesvirus infections and engineering of herpes simplex virus for gene therapy. He is a past President of the Infectious Diseases Society of America (IDSA) and was the inaugural recipient of the Distinguished Clinical Research Scholar and Educator in Residence at the NIH Clinical Center. In addition, he is the author or coauthor of more than 350 published articles and 240 book chapters.